Search

Issue
Title
Authors
Russian radiopharmaceutical Radium chloride, 223Ra: first year of use in Russia. Real practice, efficacy, and safety profile. Possibilities of combination therapy
Krylov V.V., Kochetova T.Y., Pronin A.I.
Prostate cancer metastasis to the stomach wall: a case report and literature review
Prokhorov D.G., Shkolnik M.I., Dolbov A.L., Bogomolov O.A.
Cognizance and adherence to outpatient treatment in patients with prostate cancer after local treatment: multicenter study
Perepukhov V.M., Nyushko K.M., Alekseev B.Y., Shevchuk I.M., Aleshin V.P., Movchan N.D., Mailyan O.A., Sugaipov R.L., Mangutov F.S., Biryukov V.A., Shchukina E.O., Pavlov A.Y., Dzidzaria A.G., Tsibulskii A.D., Fedotova A.D., Moshurov I.P., Kamenev D.Y., Zayniddinov A.A., Cherkasova A.Y., Keln A.A., Ratobolskikh A.V., Kupchin A.V., Borodina N.Y., Nikitin R.V., Kanukoev K.Y., Glushankova N.D., Kipriyanov E.A., Lozhkov A.A., Remizov V.V., Tevs D.V., Kovalenko R.Y., Ozornin E.V.
Prostate cancer Gleason score 6 (3 + 3): To operate or not to operate?
Dzhalilov I.B., Rybalchenko V.A., Rumyantseva D.I., Shkarupa A.G., Shkarupa D.D., Konstantinova A.M., Mamizhev E.M., Kostin A.A., Semeniakin I.V., Gadzhiev N.K.
177Lu-PSMA therapy in patients with prostate cancer. “Holiday” strategy. Pilot study
Parnas A.V., Krylov A.S., Khakulova B.M., Filimonov A.V., Pronin A.I., Ilyakov V.S., Rumyantsev A.A.
Sentinel lymph node biopsy during radical prostatectomy in patients with prostate cancer: literature review
Izmailov A.A., Chaprak A.B., Garifullin A.I., Izmailov A.A., Khasiev A.R., Farganov A.R., Akchulpan T.K., Gantsev K.S., Yatsenko T.G., Khrizman Y.N.
MRI-invisible prostate cancer: clinical and morphological characteristics
Aboyan I.A., Pakus S.M., Polyakov A.S., Redkin V.A., Badyan K.I., Shiranov K.A., Khasigov A.V.
Results of using targeted methods in repeat prostate biopsy in patients with negative results of primary systemic biopsy
Zhilov M.S., Yusufov A.G., Guspanov R.I., Kotov S.V.
Will darolutamide in double combination become the new standard of treatment for hormone-sensitive prostate cancer?
Volkova M.I., Turupaev K.A.
Metastatic lesions of the eye organs in prostate cancer. A systematic review and meta-analysis according to the PRISMA protocol 2020
Vorobev V.A., Shcherbatykh A.V., Izmailov A.A., Chaprak A.B., Farganov A.R., Khaziev A.R., Garifullin A.I., Su-Yanz K.M., Syrova A.I., Syrova A.I., Pavlov V.N.
Influence of retroelements on the risk of prostate cancer
Mustafin R.N.
Oncological outcomes of laparoscopic radical prostatectomy in patients with intermediate risk prostate cancer
Petrov S.B., Arnautov A.V., Nikulina K.A., Yakovlev V.D., Reva S.A.
Diagnostic value of PCA3, TMPRSS2:ERG and prostatic specific antigen derivatives in the detection of prostate cancer
Musaelyan A.A., Nazarov V.D., Lapin S.V., Boriskin A.G., Reva S.A., Lebedev D.G., Yakovlev V.D., Viktorov D.A., Toropovskiy A.N., Emanuel V.L., Al-Shukri S.K., Petrov S.B.
Prostate cancer with regional lymph node involvement: Is there a universal solution?
Volkova M.I., Al-Akel I.S.
Possibility of using PCA3 score without prostate massage in urine for diagnosing prostate cancer
Musaelyan A.A., Nazarov V.D., Lapin S.V., Pavlova O.N., Viktorov D.A., Toropovsky А.N., Boriskin A.G., Reva S.A., Petrov S.B.
The use of MRI/ultrasound fusion biopsy in the diagnosis of clinically significant prostate cancer
Kossov P.A., Kamolov B.S., Abdullin I.I., Baranova E.O., Shorikov M.A., Panov V.O., Turin I.E., Matveev V.B., Grigor’ev N.A., Dolgushin B.I.
Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy
Bulychkin Р.V., Tkachev S.I., Matveev V.B., Nazarenko A.V.
BRCA associated prostate cancer. BRCA heredity of one family
Izmailov A.A., Sultanbaev A.V., Menshikov K.V., Nasretdinov A.F., Musin S.I., Ayupov R.T., Sultanbaeva N.I., Ibragimov B.A., Khasiev A.R.
34th Annual Congress of the European Association of Urology in 2019: Review of oncological urology topics
Arakelyan G.A.
Thromboembolic complications in urogenital cancers: incidence, risk factors and prevention
Popov S.V., Guseynov R.G., Isakova-Sivak I.N., Sivak K.V., Skryabin O.N., Perepelitsa V.V., Sengirbaev D.I., Bunenkov N.S., Osipov P.G., Lelyavina T.A.
Prostate cancer: from diagnosis to treatment
Yagudaev D.M., Kadyrov Z.A., Astrakhantsev A.F., Bezhenar V.A., Mazurova M.P., Yagudaev D.D.
33rd Annual Congress of the European Association of Urology in 2018: Review of oncological topics
Markova A.S.
The place of multiple primary cancers in urologic oncology
Shirokorad V.I., Lupashko D.G., Doronin L.V.
The impact of the COVID-19 pandemic on cancer incidence and cancer care in patients with prostate cancer in the Siberian Federal District
Zhuikova L.D., Ananina O.A., Pikalova L.V., Kononova G.A.
Notch signaling pathway: dual role in tumour progression and therapeutic opportunities for bladder cancer
Novikova M.V., Kopnin B.P., Kopnin P.B.
Epidemiological review of multiple primary malignant neoplasms of the prostate, kidney, and bladder
Mylnikov A.M., Maslyakova G.N.
RADICAL PROSTATECTOMY FOR PATIENTS WITH CLINICALLY LOCALIZED AND LOCALLY ADVANCED PROSTATE CANCER: THE REMOTE RESULTS OF TREATEMENT
Grygorenko V.N., Danilets R.O., Mezheritskiy S.N.
Comparing the efficacy of laparoscopic and open radical prostatectomy: analysis of treatment outcomes in patients with prostate cancer treated in three federal centers
Nyushko K.M., Perepukhov V.M., Kozlova P.S., Chaykov V.S., Shchukina E.O., Dementyev I.O., Krasheninnikov A.A., Shevchuk I.M., Alekseev B.Y., Kaprin A.D., Ivanov S.A., Karyakin O.B.
Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radical radiotherapy
Solodkiy V.A., Pavlov A.Y., Tsybul’skiy A.D.
Treatment of localized prostate cancer depending on the oncological risk group
Nizamova R.S., Andreeva R.D., Vozdvizhensky M.O.
High-intensity focused ultrasound (HIFU) in the treatment of prostate cancer
Alyaev Y.G., Krupinov G.E., Grigoryan V.A., Bezrukov E.A., Amosov A.V., Chaliy M.E., Brouk Y.F.
Modern approaches to treatment of castration-resistant prostate cancer using targeted radionuclide therapy in patients with bone metastases
Perepukhov V.M., Alekseev B.Y., Nyushko K.M.
Salvage high-dose-rate brachytherapy for recurrent prostate cancer
Kaprin A.D., Ivanov S.A., Karyakin O.B., Obuhov A.A., Biryukov V.A., Borysheva N.B., Sanin D.B., Lepilina O.G., Smolkin A.L., Dem’yanovich A.V., Minaeva N.G., Mikhaylovskiy N.V.
Prospective study of prostate cancer detection using multiparametric magnetic resonance imaging ultrasound-guided fusion, standard, and saturation biopsy
Petov V.S., Timofeeva E.Y., Bazarkin A.K., Morozov A.O., Taratkin M.S., Ganzha T.M., Danilov S.P., Chernov Y.N., Abdusalamov A.F., Amosov A.V., Enikeev D.V., Krupinov G.E.
Prevalence of mutations in DNA repair genes in Russian patients with metastatic castration-resistant prostate cancer
Mailyan O.A., Kalpinskiy A.S., Reshetov I.V., Anzhiganova Y.V., Nyushko K.M., Kaprin А.D., Golovashchenko M.P., Kokin S.P., Stakanov V.A., Alekseev B.Y.
11C–Choline PET / CT in the detection of prostate cancer relapse in patients with rising PSA
Aslanidis I.P., Pursanova D.M., Mukhortova O.V., Silchenkov A.V., Roshin D.A., Koryakin A.V., Ivanov S.A., Shirokorad V.I.
Molecular diagnosis of prostate cancer: Topical issues
Knyazev E.N., Fomicheva K.A., Nyushko K.M., Kaprin A.D., Alekseev B.Y., Shkurnikov M.Y.
DIFFICULTIES IN DETERMINING THE STAGE OF PROSTATE CANCER
Lukianov I.V.
Effectiveness and safety of darolutamide as a component of combination therapy in patients with prostate cancer
Alekseev B.Y., Perepukhov V.M., Nyushko K.M.
Multicenter non-interventional study of prevalence of homologous recombination gene mutations and approaches to treatment of metastatic castration-resistant prostate cancer in Russia (ADAM)
Alekseev B.Y., Anzhiganova Y.V., Sultanbaev A.V., Bystrov A.A., Orlov A.S., Gopp G.V., Kopyltsov A.V., Lykov A.V., Atduev V.A., Alekseeva G.N., Rodygin L.M., Varlamov S.A., Shestakov A.V., Maturov M.R., Urmantsev M.F., Lankina L.V., Parsadanova E.L., Startsev V.Y., Vedrova O.V., Andreev S.Y., Perevoshchikov A.A., Mailyan O.A., Kalpinskiy A.S.
Clinical significance of mutations in DNA repair genes in patients with metastatic prostate cancer
Mailyan O.A., Kalpinskiy A.S., Reshetov I.V., Nyushko K.M., Alekseev B.Y., Kokin S.P., Stakanov V.A., Golovashchenko M.P.
Modern drug therapy of prostate cancer through the example of Moscow
Polyakova K.I., Fisun A.G., Govorov A.V., Krysanova V.S., Andreev D.A., Ermolaeva T.N., Andreyashkina I.I., Zavyalov A.A., Davydovskaya M.V., Kokushkin K.A.
The problem of choosing the tactics of managing patients with high and very high risk of prostate cancer: a review of the literature
Buevich N.N., Protsenko S.A., Nosov A.K., Reva S.A., Artemyeva A.S., Berkut M.V.
Artificial intelligence in diagnosis of prostate cancer using magnetic resonance imaging. New approach
Aboyan I.A., Redkin V.A., Nazaruk M.G., Polyakov A.S., Pakus S.M., Lemeshko S.I., Hasigov А.V.
Drug treatment opportunities of the elderly patients with the metastatic castration-resistant prostate cancer
Solodkiy V.A., Pavlov A.Y., Gafanov R.A., Garmash S.V., Kravtsov I.V., Fastovets S.V., Ivashin A.K.
Recurrence of prostate cancer of rare location: magnetic resonance diagnosis and treatment. Clinical case
Solodkiy V.A., Pavlov A.Y., Rebrikova V.A., Tsibulskii A.D., Kriger A.V.
Radiotherapy for patients with locoregional and oligometastatic relapses of prostate cancer after radical prostatectomy
Bulychkin P.V., Tkachev S.I., Matveev V.B., Klimov A.V., Kossov F.A.
Evaluation of heterogeneous factors of low-grade prostate cancer in patients before and after radical prostatectomy
Veliev E.I., Goncharuk D.A., Sokolov E.A., Ivkin E.V., Paklina O.V., Setdikova G.R.
Robot-assisted radical prostatectomy in patients after endoscopic surgeries on the prostate
Guliev B.G., Ilyin D.M., Kharchenko P.V., Talyshinskiy A.E., Krylov O.A.
Comparative analysis of adverse events using different methods of prostate biopsy
Keln A.A., Zyryanov A.V., Izmailov A.A., Zotov P.B., Znobishchev V.G., Ponomarev А.V.
Combined chemohormonalradiation treatment of highand very-high-risk non-metastatic prostate cancer
Kaprin A.D., Troyanov A.V., Ivanov S.A., Karyakin O.V.
When repeated biopsy dramatically changes treatment tactics in metastatic castration-refractory prostate cancer with neuroendocrine transformation: clinical case and literature review
Usoltseva I.S., Parsadanova E.L., Kim Y.K.
THE USE OF QUALITY OF LIFE AUTOMATIZED ASSESSMENT TECHNOLOGY IN PATIENTS IN CLINICAL PRACTICE OF THE ONCOUROLOGICAL DEPARTMENT
Shirokorad V.I., Shtevnina Y.I., Shvyrev S.L., Makhson A.N., Dolgih D.V.
Metachronous development of breast and prostate cancer (case report)
Gordiev M.G., Druzhkov M.O., Dulesova A.Y., Nikitin A.G., Ulyanin M.Y., Platonova E.V., Brovkina O.I.
Clinical and economic impact of modern pharmaceuticals on reducing mortality from hormone-sensitive prostate cancer with high-volume disease
Avxentyev N.A., Nyushko K.M., Makarova Y.V.
Neuroendocrine prostate cancer
Safina S.Z., Isyangulova A.Z.
Basic characteristics and features of the molecular genetic test systems designed for non-invasive diagnostics and prognosis of prostate cancer and bladder cancer
Mikhaylenko D.S., Sergienko S.A., Alekseev B.Y., Kaprin A.D., Nemtsova M.V.
Genetic predisposition markers for prostate cancer
Kanaeva M.D., Orobtsova I.E.
Tissue expression of LC3B autophagy marker as a potential biomarker of prostate cancer recurrence after treatment with high-intensity focused ultrasound (pilot study)
Voronina E.S., Fomkin R.N., Bucharskaya A.B., Palatova T.V., Maslyakova G.N., Fomkina O.A.
Small cell prostate cancer: a clinical case
Ivanov A.M., Skvortsov I.Y., Delektorskaya V.V., Gorbunova V.A.
TRANSFUSION THERAPY IN THE RADICAL SURGICAL TREATMENT OF PATIENTS WITH URINARY BLADDER AND PROSTATE CANCERS
Bolikhova N.A., Petrova M.V., Kostin А.А.
Organizing the national prostate cancer audit in the UK (review of foreign literature)
Andreev D.A., Zavyalov A.A.
Surgical treatment of patients with high-risk prostate cancer: long-term outcomes and prognostic factors
Alekseev B.Y., Krasheninnikov A.A., Nyushko K.M., Vorobyev N.V., Kaprin A.D.
PROSTATIC INTRAEPITHELIAL NEOPLASIA: HISTOLOGICAL ASSOCIATIONS
Gorbunova E.N., Krupin V.N., Davydova D.A., Artifeksova A.A.
Modern principles of diagnosis and treatment of patients with neuroendocrine carcinoma of the prostate
Startsev V.Y., Shpof E.V., Krivonosov D.I.
Computed tomography-guided pararectal prostate fusion biopsy
Kopylov A.A., Gorelov V.P., Margaryants N.B., Gorelov S.I.
SATURATION BIOPSY OF THE PROSTATE (REVIEW)
Sadchenko A.V., Govorov A.V., Pushkar D.Y., Vasiliev A.O.
PCA3 IS A TRUE ONCOMARKER OF PROSTATE CANCER: A REVIEW OF LITERATURE
Sidorenkov A.V., Pushkar D.Y.
Experience of robot-assisted radical prostatectomy after hemiablation of the prostate with high-intensity focused ultrasound using the Focal One robotic platform: clinical case
Alaverdyan A.I., Govorov A.V., Vasilyev A.О., Kolontarev K.B., Prilepskaya E.A., Pushkar D.Y.
Ductal prostate cancer
Biryukov V.A., Gorban N.A., Karyakin O.B., Neledov D.V., Kaprin A.D.
THE PRETREATMENT PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME: CLINICAL AND PROGNOSTIC VALUES IN PATIENTS WITH PROSTATE CANCER
Zharinov G.M., Bogomolov O.A.
Somatostatin analogs in the treatment of castrate-resistant prostate cancer: efficacy and tolerability
Kolesnikov G.P., Semkov A.S., Bystrov A.A., Naumova I.N.
APHIG: a new multiparameter index for prostate cancer
Sergeeva N.S., Skachkova T.E., Alekseev B.Y., Yurkov E.F., Pirogov S.A., Gitis V.G., Marshutina N.V., Kaprin A.D.
COMPARATIVE ANALYSIS OF THE BACTERIAL POPULATION OF THE PROSTATE IN ITS CANCER AND BENIGN HYPERPLASIA
Kogan M.I., Naboka Y.L., Vasilyeva L.I., Chibichyan M.B., Ilyash A.V., Vasilyev O.N.
High-intensity focused ultrasound (HIFU) in the treatment of localized prostate cancer. From total to focal ablation
Aboyan I.A., Pakus S.M., Badyan K.I., Hasigov A.V., Galstyan A.M.
Intermediate results of the observational program on the Eligard (45 mg) administration in the clinical practice
Matveev V.B., Markova A.S.
MOLECULAR MARKERS FOR METASTATIC PROSTATE ADENOCARCINOMA
Kunin I.S., Boboev M.M., Kutsenko O.S., Mostovich L.A., Aidagulova S.V., Grigorieva E.V.
Time to biochemical recurrence after radical prostatectomy is an important predictor of clinical progression, distant metastases and cancer-specific death
Veliev E.I., Sokolov E.A., Loran O.B., Petrov S.B., Lukyanov I.V., Seregin A.V., Bogdanov A.B.
VERIFICATION OF A TUMOR LESION OF INTRAPELVIC LYMPH NODES AFTER RADICAL PROSTATECTOMY. THE FIRST EXPERIENCE
Kapustin V.V., Shirokorad V.I., Gromov A.I., Koshurnikov D.S.
THE PROGNOSTIC AND DIAGNOSTIC VALUE OF REPEATED TRANSRECTAL PROSTATE SATURATION BIOPSY
Kurdzhiev M.A., Govorov A.V., Kovylina M.V., Pushkar D.Y.
USE OF NEURAL NETWORK SIMULATION TO MONITOR PATIENTS UNDERGOING RADICAL PROSTATECTOMY
Lukyanov I.V., Demchenko N.A.
PROGNOSTIC FACTORS OF PROSTATE CANCER BEFORE AND AFTER RADICAL PROSTATECTOMY
Veliev E.I., Okhrits V.E., Obeid A.K.
RADICAL RETROPUBIC PROSTATECTOMY: THE FIRST RUSSIAN EXPERIENCE OF 15-YEAR FOLLOW-UP AFTER SURGERY
Veliev E.I., Petrov S.B., Loran O.B., Sokolov E.A., Seregin A.V., Lukyanov I.V.
RESULTS OF A GOAL-ORIENTED PROSTATE CANCER SCREENING PROGRAM IN THE PENZA REGION
Engalychev F.S., Mironov M.A., Galkina N.G., Galkin A.V., Durdenevsky N.B., Syskova M.A.
QUALITY OF LIFE IN PATIENTS OVER 70 YEARS OLD AFTER RADICAL SURGERY FOR PROSTATE CANCER
Bormotin A.V., Reva I.A., Dyakov V.V., Bernikov A.N., Pushkar D.Y.
Prognostic significance of germline mutations in DNA homologous recombination repair genes in patients with primary metastatic prostate cancer
Muradkhanau A.I., Sinyavskaya E.S., Rolevich A.I., Goncharova R.I., Evseev N.E., Zakharova V.A., Smal M.P., Parmon M.L., Semenov S.A., Krasny S.A., Polyakov S.L.
Anatomical aspects of vessel-sparing radiation therapy for prostate cancer
Novikov R.V., Lyasovich G.A., Ponomareva O.I., Karandashov V.K., Burovik I.A., Tyatkov S.A., Kulish A.V., Protoshchak V.V., Novikov S.N.
Quantitative single-photon emission computed tomography/computed tomography in assessing the effectiveness of radium-223 dichloride therapy
Nikolaeva E.A., Krylov A.S., Ryzhkov A.D., Geliashvili T.M., Pavlova A.V., Goryainova A.Y., Murashko R.A.
Methodological aspects of implantation of a Russian prostate-rectum spacer based on stabilized hyaluronic acid of non-animal origin
Novikov R.V., Zhivulina T.V., Sysoeva V.V., Protoshchak V.V., Karandashov V.K., Gozalishvili S.M., Novikov S.N.
The first experience of using prostate cancer organoids as a model for personalized selection of drugs
Nikulin S.V., Alekseev B.Y., Poloznikov A.A., Osipyants A.I.
High-dose-rate brachytherapy as monotherapy for prostate cancer: 5-year results
Solodkiy V.A., Pavlov A.Y., Tsybulskii A.D., Dzidzaria A.G., Sorokin A.S., Mirzakhanov R.I.
Influence of biopsy cores number performed with targeted prostate biopsy on the likelihood of a positive result in patients with clinically significant prostate cancer
Zyryanov A.V., Gulin G.A., Rubtsova N.A., Mager V.O., Putintsev A.E., Kuznetsova S.G., Kuznetsova D.D.
Current view on nerve-sparing radical prostatectomy
Sokolov E.A., Veliev E.I., Veliev R.A.
Evaluation of safety and advisability of salvage lymph node dissection in patients with lymphogenic metastases of prostate cancer after radical treatment
Evsukova O.I., Chernyaev V.A., Khalmurzaev O.A., Khafizov K.A., Khachaturyan A.V., Tkhakokhov M.M., Matveev V.B.
Chemotherapy in the treatment of metastatic prostate cancer: the present state of the problem
Alekseev B.Y.
EXPERIENCE WITH A HISTOSCANNING APPARATUS USED IN THE DIAGNOSIS OF RECURRENT PROSTATE CANCER AFTER HIFU ABLATION
Glybochko P.V., Alyaev Y.G., Amosov A.V., Krupinov G.E., Ganzha T.M., Obukhov A.A., Amosov N.A.
CYSTECTOMY WITH THE PROSTATE AND SEMINAL VESICLES BEING PRESERVED: PROGNOSIS AND REALITY
Gotsadze D.T., Chakvetadze V.T.
TADALAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMY: A REVIEW
Govorov A.V., Pushkar D.Y.
PROGNOSTIC FACTORS OF POSITIVE RESULTS OF MULTIFOCAL TRUS-GUIDED VESICOURETHRAL ANASTOMOSIS BIOPSY IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
Demeshko P.D., Karman A.V., Sukonko O.G., Krasny S.A.
THE ACTIVITY OF PROTEOLYTIC ENZYMES AND THEIR INHIBITORS IN THE SECRETION OF THE PROSTATE IN ITS BENIGN HYPERPLASIA AND CANCER
Kogan M.I., Chernogubova E.A., Chibichyan M.B., Matishov D.G.
1 - 100 of 271 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"